| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/12/2006 | EP1644353A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 04/12/2006 | EP1644345A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 04/12/2006 | EP1644343A1 5-substituted quinazolinone derivatives |
| 04/12/2006 | EP1644335A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 04/12/2006 | EP1643988A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 04/12/2006 | EP1446403B1 Aryl substituted oxazolidinones with antibacterial activity |
| 04/12/2006 | EP1349854B1 Hetaryl substituted homotetramic and homotetronic acids and the use thereof as pesticides |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 04/12/2006 | EP1336605B1 Substituted phenol derivatives or salts thereof as inhibitors of coagulation factor x |
| 04/12/2006 | EP1302466B1 Benzoxazole compound, process for producing the same, and herbicide |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1087981B1 Prenyl transferase inhibitors |
| 04/12/2006 | EP1003736B1 Substituted 4-benzoyl-pyrazoles |
| 04/12/2006 | CN1759115A Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 04/12/2006 | CN1759114A Heterocyclic N-aryl carboxamides as cytokine inhibitors |
| 04/12/2006 | CN1759112A Benzimidazole derivatives and their use for modulating the GABA- SB A /SB receptor complex |
| 04/12/2006 | CN1759111A Imidazol-4-yl-ethynyl-pyridine derivatives |
| 04/12/2006 | CN1759110A Pyrazole derivative |
| 04/12/2006 | CN1250533C Novel azoles having an insecticidal action |
| 04/12/2006 | CN1250532C Process for preparation of oxo-oxazoline or alloamino acid derivatives |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026342 treating fibrotic lung diseases and fibrotic hypertrophy or fibrosis of prostate, liver, the pleura, pancreas or bowel wall with saturated and unsaturated azoles and salts, e.g., 3-[2-phenyl-2-oxoethyl]-4,5-dimethyl-thiazolium salt |
| 04/11/2006 | US7026341 Hetaryl substituted homotetramic and homotetronic acids and their use thereof as pesticides |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026334 Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 04/11/2006 | US7026321 piperazine derivatives, e.g., (2R)-1-(2-methylbenzothiazol-5-yloxy)-3-[4-({5-[4-(trifluoromethyl)phenyl](4,5-dihydroisoxazol-3-yl)}methyl)piperazinyl]propan-2-ol; treating diabetes, arrhythmia, intermittent claudication, angina, congestive heart disease, and myocardial infarction |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | US7025816 Mixture containing oil soluble polymer |
| 04/11/2006 | CA2281702C (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/11/2006 | CA2181570C Metalloproteinase inhibitors |
| 04/11/2006 | CA2162382C Intercalators having affinity for dna and methods of use |
| 04/07/2006 | CA2583572A1 Thiazolyl mglur5 antagonists and methods for their use |
| 04/06/2006 | WO2006036994A2 Modulators of crth2, cox-2 and faah |
| 04/06/2006 | WO2006036670A1 Sulfonamide compounds |
| 04/06/2006 | WO2006036527A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | WO2006036497A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006035954A1 Carbostyril compound |
| 04/06/2006 | WO2006035685A1 Intermediate of 6-substituted-1-methyl-1-h-benzimidazole derivative and method for producing same |
| 04/06/2006 | WO2006035459A1 An improved process for the production of derivatives of thiozolidinediones and their precursors |
| 04/06/2006 | WO2006035068A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/06/2006 | WO2006034965A1 Process for the purification of ziprasidone |
| 04/06/2006 | WO2006034964A1 Process for preparing ziprasidone |
| 04/06/2006 | WO2006034833A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | WO2006034789A1 Proline derivatives |
| 04/06/2006 | WO2006023460A3 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 04/06/2006 | WO2006004793A3 Hetero isonipecotic modulators of vanilloid vr1 receptor |
| 04/06/2006 | WO2005100331A3 Antidiabetic agents |
| 04/06/2006 | WO2005049532A3 A process for purification |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 04/06/2006 | US20060074237 Pyridines |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074114 Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids |
| 04/06/2006 | US20060074090 1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety |
| 04/06/2006 | US20060074075 including cystic fibrosis transmembrane conductance regulator ("CFTR"), used for treating genetic disorders; respiratory system disorders |
| 04/06/2006 | US20060074071 Substituted arylamides |
| 04/06/2006 | US20060074069 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2582225A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | CA2581823A1 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581737A1 Proline derivatives |
| 04/06/2006 | CA2581426A1 Sulfonamide compounds |
| 04/06/2006 | CA2581322A1 Process for preparing ziprasidone |
| 04/06/2006 | CA2580811A1 Carbostyril compound |
| 04/06/2006 | CA2577467A1 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | CA2577185A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/05/2006 | EP1641790A1 Process for the preparation of insulin sensitizer and intermediate compound thereof |
| 04/05/2006 | EP1641789A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 04/05/2006 | EP1641765A1 Aryl-heteroaromatic products, compositions containing same and use thereof |
| 04/05/2006 | EP1641757A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/05/2006 | EP1641756A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 04/05/2006 | EP1641734A1 Method for producing c1-c15 fragments of epothilones and the derivatives thereof |
| 04/05/2006 | EP1641453A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | CN1757066A Optical recording materials having high storage density |
| 04/05/2006 | CN1756824A 有机电致发光元件 Organic electroluminescent element |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249024C Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022846 Metabolites of prinomastat and their synthesis |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022725 Isoxazole derivatives |
| 04/04/2006 | US7022723 Heterocyclic compounds |
| 04/04/2006 | US7022722 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |